August 2022: TempTraq by Blue Spark Technologies Inc

Early fever detection leads to better patient care.

Image credit: PR Newswire

Blue Spark Technologies Inc produces TempTraq, an FDA Cleared Class II medical device that gives Healthcare providers the first wireless continuous temperature monitor in the form of a soft, comfortable, disposable patch. TempTraq can significantly improve the way temperature is measured in the clinical environment and provides clinicians with a quicker, easier, and more effective way to measure temperature.

Accuracy and equivalency in three hospital studies:
  • Cleveland Clinic
  • University Hospitals Seidman Cancer Center
  • Cincinnati Children’s Hospital

 

In a clinical study conducted by University Hospitals Seidman Cancer Center, TempTraq was shown to detect temperature rises earlier than the standard of care by a median of 140.1 minutes (range of 30-180 minutes) with bone marrow transplant patients.

WT thinks this is what earns TempTraq the title “Innovation of the Month”.

Jürgen Thalmayer
August 1, 2022

August 2022

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

ams Introduces AS6221, A Digital Temperature Sensor, Delivering Accurate Data for Wearables

ams announced the launch of the AS6221, a digital temperature sensor, which the company claims to...

Text-To-Speech: Secure New Innovative Market For Your Business

TTS or Text-to-speech is playing an important role in everyday interactions between brands and...

IDC Profiles Hearables Makers Bragi, Nuheara, and Waverly Labs as IDC Innovators

International Data Corporation (IDC) has published a new IDC Innovators report...

MC10 Collaborates with AbbVie for Multiple Sclerosis Clinical Trials Using BioStamp nPoint system

MC10 Collaborates with AbbVie for Multiple Sclerosis Clinical Trials Using BioStamp nPoint system
Discover more